Loading...
Embecta Corp.
EMBC•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$11.73
$0.35(3.08%)
Embecta Corp. (EMBC) Financial Performance & Income Statement Overview
Review Embecta Corp.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.21%
↑ 0.21%
Operating Income Growth
-24.70%
↓ 24.70%
Net Income Growth
11.22%
↑ 11.22%
Operating Cash Flow Growth
-47.27%
↓ 47.27%
Operating Margin
16.09%
↑ 16.09%
Gross Margin
63.46%
↑ 63.46%
Net Profit Margin
4.83%
↑ 4.83%
ROE
-6.93%
↓ 6.93%
ROIC
20.18%
↑ 20.18%
Embecta Corp. (EMBC) Income Statement & Financial Overview
Review Embecta Corp.'s (EMBC) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $261.90M | $286.10M | $272.50M | $287.20M |
| Cost of Revenue | $104.80M | $112.30M | $82.40M | $103.00M |
| Gross Profit | $157.10M | $173.80M | $190.10M | $184.20M |
| Gross Profit Ratio | $0.60 | $0.61 | $0.70 | $0.64 |
| R&D Expenses | $20.30M | $19.80M | $20.40M | $18.40M |
| SG&A Expenses | $81.10M | $96.80M | $85.70M | $92.30M |
| Operating Expenses | $128.40M | $147.60M | $134.20M | $112.40M |
| Total Costs & Expenses | $206.20M | $259.90M | $216.60M | $215.40M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $27.90M | $29.00M | $27.80M | $27.80M |
| Depreciation & Amortization | $11.90M | $7.80M | $11.10M | $10.20M |
| EBITDA | $39.10M | $34.00M | $65.90M | $82.00M |
| EBITDA Ratio | $0.15 | $0.12 | $0.24 | $0.29 |
| Operating Income | $28.70M | $26.20M | $55.90M | $71.80M |
| Operating Income Ratio | $0.11 | $0.09 | $0.21 | $0.25 |
| Other Income/Expenses (Net) | -$29.40M | -$33.20M | -$28.90M | -$29.30M |
| Income Before Tax | -$700000.00 | -$7.00M | $27.00M | $9.90M |
| Income Before Tax Ratio | -$0.003 | -$0.02 | $0.10 | $0.03 |
| Income Tax Expense | -$700000.00 | -$21.60M | $12.30M | -$19.00M |
| Net Income | -$700000.00 | $14.60M | $14.70M | $28.90M |
| Net Income Ratio | -$0.003 | $0.05 | $0.05 | $0.10 |
| EPS | -$0.01 | $0.25 | $0.25 | $0.50 |
| Diluted EPS | -$0.01 | $0.25 | $0.25 | $0.50 |
| Weighted Avg Shares Outstanding | $57.95M | $0.00 | $58.80M | $57.69M |
| Weighted Avg Shares Outstanding (Diluted) | $58.62M | $0.00 | $57.84M | $57.81M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan